Skip to main content
All lobbying filings

Compass Pathways Inc.

Compass Pathways Inc. filed a Q2 report for Compass Pathways Inc. on July 17, 2026.

Lobbying for Compass Pathways Inc. · Biotechnology company

As filed: COMPASS PATHWAYS INC. for COMPASS PATHWAYS INC.

All filings by Compass Pathways Inc. · Everything Compass Pathways Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Expenses
$130,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New York

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem